The Competitive Advantage of Chong Keun Dang Pharms.

소개글

The Competitive Advantage of Chong Keun Dang Pharms.에 대한 보고서 자료입니다.

목차

- 목 차-

1. Prospects and Top-pick Pharmaceutical Industries in Korea.

1.1 Korean Pharmaceutical Industries Structure Analysis

1.2 Core Issues about Survival for Korean Pharmaceutical Industries.

2. The Competitive Advantage of Chong Keun Dang

2.1 High Profitability in Senile Disease Sector.

2.2 R&D Investment and Original Medicine Development Capabilities

2.3 Adapting to Governmental Risks

2.4 Global Sectors

3. Suggestions for Sustainable Competitiveness of Chong Keun Dang

3.1 M&A Issue

3.2 For Sustainable Competitiveness : One-Way Focus Strategy

본문내용

Even though pharmaceutical industries have expanded growth themselves with increasing demand of medicine, it is expected that they will have difficulty in facing with risks. One is that pharmaceutical industries must face with a governmental risk such as a positive list system that was set up for stabilization of medicine price, thereby enduring with decreasing medicine price. Medicine demand is still stable, but medicine prices have repeatedly decreased over the few years. Meanwhile, medicine development costs are expected to increase steadily, since they must satisfy the tricky standard required by medicine evaluation process like GMP and compete for multinational incorporations investing a lot of money into original medicine R&D. In these circumstances, if Korean pharmaceuticals companies don’t have any specific strategies to manufacture profitable medicine products compared with decreased price, they will have difficulty in surviving in the positive list system mechanism, and competing for multinational pharmaceutical incorporations.
As long as medicine prices go down and development costs go up, futuristic survival for Korean pharmaceuticals will be associated with how profitable they are. This profitability problem is expected to unravel with four determinants: one-way focus strategy and profitability toward senile disease, high R&D investment rate and original medicine development capabilities, adapting to governmental risks, and stable positioning in global sectors. In these perspectives, It is allegedly said that Chong Keun Dang Pharm(CKD pharms.) have enough capabilities and potentials to survive in the future market, satisfying four determinants that were mentioned above. Therefore, it is required that the competitive advantage of Chong Keun Dang Pharm. Should be discussed in analytical way.

키워드

연구개발,   종근당,   산업분석,   FTA,   기업분석,   제약산업,   M&A,   경쟁우위